Non-Genomic Control of Dynamic MYCN Gene Expression in Liver Cancer

Upregulated gene expression is restricted to specialized cell populations such as EpCAM cancer stem cells in liver cancer, regardless of DNA amplification and mutation. Here, we reviewed the role of gene expression in liver homeostasis, regeneration, and tumorigenesis, and discussed the potential no...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in oncology Vol. 10; p. 618515
Main Authors: Qin, Xian-Yang, Gailhouste, Luc
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 16-04-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Upregulated gene expression is restricted to specialized cell populations such as EpCAM cancer stem cells in liver cancer, regardless of DNA amplification and mutation. Here, we reviewed the role of gene expression in liver homeostasis, regeneration, and tumorigenesis, and discussed the potential non-genomic mechanisms involved in controlling gene expression in liver cancer, with a focus on inflammation-mediated signal transduction and microRNA-associated post-transcriptional regulation. We concluded that dynamic gene expression is an integrated consequence of multiple signals in the tumor microenvironment, including tumor growth-promoting signals, lipid desaturation-mediated endoplasmic reticulum stress adaptation signals, and tumor suppressive miRNAs, making it a potential predictive biomarker of tumor stemness and plasticity. Therefore, understanding and tracing the dynamic changes and functions of gene expression will shed light on the origin of liver tumorigenesis at the cellular level and the development of novel therapeutic and diagnostic strategies for liver cancer treatment.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Edited by: Yusuke Suenaga, Chiba Cancer Center, Japan
Reviewed by: Shoma Tsubota, Nagoya University, Japan; Alexander Schramm, Essen University Hospital, Germany
This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2020.618515